Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.4 % BTX opened at $1.80 on Friday. The company has a market cap of $105.59 million, a price-to-earnings ratio of -0.79 and […]
More Stories
UBS Group Initiates Coverage on Pagaya Technologies (NASDAQ:PGY)
UBS Group initiated coverage on shares of Pagaya Technologies (NASDAQ:PGY – Free Report) in a research note published on Friday...
Ucommune International (NASDAQ:UK) vs. ExlService (NASDAQ:EXLS) Head-To-Head Contrast
Ucommune International (NASDAQ:UK – Get Free Report) and ExlService (NASDAQ:EXLS – Get Free Report) are both finance companies, but which...
Head to Head Review: SBC Medical Group (NASDAQ:SBC) vs. Teladoc Health (NYSE:TDOC)
SBC Medical Group (NASDAQ:SBC – Get Free Report) and Teladoc Health (NYSE:TDOC – Get Free Report) are both small-cap medical...
Financial Analysis: TSS (TSSI) & The Competition
Institutional and Insider Ownership 44.6% of shares of all “Management consulting services” companies are held by institutional investors. 30.5% of...
Comparing Simon Property Group (NYSE:SPG) and Farmland Partners (NYSE:FPI)
Simon Property Group (NYSE:SPG – Get Free Report) and Farmland Partners (NYSE:FPI – Get Free Report) are both finance companies,...
Brokerages Set TPG RE Finance Trust, Inc. (NYSE:TRTX) Price Target at $9.08
TPG RE Finance Trust, Inc. (NYSE:TRTX – Get Free Report) has been assigned an average rating of “Moderate Buy” from...